AniLabsystems offers reliable method for testing B. Pertussis infections. Precise diagnosis of pertussis is needed for effective treatment of patients, for isolation of unvaccinated infants at risk, and for differentiation of pertussis from atypical diseases and chronic infections.
AniLabsystems offers species-specific tests for Chlamydia pneumoniae IgG, IgA and IgM antibodies based on the latest enzyme immunoassay (EIA) technology as well as on micro immunofluorescence methoodology (MIFA).
AniLabsystems' species-specific tests for Chlamydia trachomatis IgG and IgA antibodies pioneers in applying a peptide based enzyme immunoassay (EIA) technology. These tests are especially useful when antigens or viable organisums are not detectable, such as in complicated and prolonged infections.
AniLabsystems have developed new unique species-specific EIAs for the detection of IgG, IgA and IgM-class antibodies against Mycoplasma pneumoniae in human serum or plasma.
AniLabsystems' Toxoplasma gondii avidity EIA kit provides a method of detect and confirm acute phase prmary infection. In the Avidity assay, the antigen binding avidity of IgG antibodies is measured. The low avidity antibodies produced at the early stages of infection are distinguished from the high avidity antibodies which reflect past immunity.
